IMEDS, our Innovation in Medical Evidence Development and Surveillance program, provides researchers with access to a large database of de-identified healthcare claims data.
"IMEDS appropriately shifts the focus from debates over differing methods and data to the underlying clinical and public health questions of concern," said during his #SubHealth testimony on 7/25/18. For more info: #RWE #drugsafety